| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56,1 k € | +90.8% | 29,4 k € | -4.3% | 30,7 k € | +33.6% | 23,0 k € | -93.6% | 361,1 k € | +975.3% | 33,6 k € | -30.4% | 48,3 k € | -48.2% | 93,2 k € | — | — | — | — | — | — | |||||||
| Gross margin | 43,8 k € | +191.2% | 15,1 k € | -3.8% | 15,6 k € | +6.2% | 14,7 k € | -8.2% | 16,0 k € | -25.9% | 21,7 k € | -29.1% | 30,5 k € | -55.8% | 69,1 k € | +157.9% | 26,8 k € | +30.5% | 20,5 k € | +597.7% | 2,9 k € | -64.4% | 8,3 k € | +108.9% | -93,1 k € | +41.0% | -157,8 k € | |
| EBITDA | 43,1 k € | +227.2% | 13,2 k € | -7.0% | 14,2 k € | -2.6% | 14,5 k € | +0.5% | 14,5 k € | -20.4% | 18,2 k € | -18.5% | 22,3 k € | -67.1% | 67,7 k € | +166.0% | 25,5 k € | +27.6% | 20,0 k € | +733.7% | 2,4 k € | -68.3% | 7,6 k € | +107.9% | -95,8 k € | +47.9% | -183,9 k € | |
| Operating profit | 26,0 k € | +97.8% | 13,2 k € | -7.0% | 14,2 k € | -2.6% | 14,5 k € | +2432.3% | -623,0 € | -136.2% | 1,7 k € | -62.1% | 4,5 k € | -90.5% | 47,7 k € | +781.8% | 5,4 k € | -72.9% | 20,0 k € | +733.7% | 2,4 k € | -68.7% | 7,6 k € | +110.1% | -75,4 k € | +64.4% | -212,1 k € | |
| Profit/loss | -13,5 k € | -203.3% | 13,1 k € | -7.3% | 14,1 k € | -2.4% | 14,5 k € | +2258.3% | -671,0 € | -134.0% | 2,0 k € | +78.9% | 1,1 k € | -97.0% | 36,4 k € | +585.0% | 5,3 k € | -67.9% | 16,6 k € | +263.1% | -10,2 k € | -153.5% | 19,0 k € | +120.2% | -93,9 k € | +56.5% | -216,0 k € | |
| Equity | 93,3 k € | -12.7% | 106,9 k € | +14.0% | 93,8 k € | +17.8% | 79,6 k € | +22.2% | 65,2 k € | -1.0% | 65,8 k € | +3.1% | 63,9 k € | +154.2% | -117,8 k € | +23.6% | -154,2 k € | +3.3% | -159,5 k € | +9.4% | -176,1 k € | -6.1% | -165,9 k € | +10.3% | -184,9 k € | -103.2% | -91,0 k € | |
| Total assets | 554,5 k € | +400.1% | 110,9 k € | +18.0% | 94,0 k € | -53.6% | 202,7 k € | +12.9% | 179,6 k € | +142.8% | 74,0 k € | +0.4% | 73,7 k € | -45.3% | 134,6 k € | +21.5% | 110,8 k € | +8.4% | 102,3 k € | +2995.9% | 3,3 k € | -91.2% | 37,5 k € | -71.7% | 132,2 k € | -44.3% | 237,6 k € | |
| Cash | 264,8 € | -99.4% | 41,8 k € | -33.1% | 62,5 k € | +25106.9% | 248,0 € | -95.3% | 5,3 k € | -58.3% | 12,8 k € | +274.2% | 3,4 k € | +50.5% | 2,3 k € | -64.6% | 6,4 k € | +1799.7% | 337,0 € | -42.2% | 583,0 € | -96.0% | 14,6 k € | +2348.6% | 597,0 € | -98.1% | 31,8 k € | |
| Debts | 461,2 k € | +11386.5% | 4,0 k € | +1708.6% | 222,0 € | -99.8% | 123,1 k € | +7.5% | 114,5 k € | +1302.9% | 8,2 k € | -16.9% | 9,8 k € | -96.1% | 252,4 k € | -4.8% | 265,0 k € | +1.2% | 261,7 k € | +48.0% | 176,9 k € | -12.0% | 200,9 k € | -35.6% | 312,1 k € | -3.5% | 323,6 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | ||||||||||||||
Public limited company · Lokeren · incorporated on 26/10/2010
Public limited company loss-making in the latest fiscal year. Cash position declining (-99.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
LINEA TROVATA BIOCONSTRUCT is a Public limited company incorporated in 2010. Its main activity is: Construction of buildings. Its registered office is in Lokeren.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette